According to Medpace's latest financial reports the company's current EPS (TTM) is HK$68.87. In 2022 the company made an earnings per share (EPS) of HK$59.14 an increase over its 2021 EPS that were of HK$39.37.
Year | EPS | Change |
---|---|---|
2023 (TTM) | HK$69.32 | 17.22% |
2022 | HK$59.14 | 50.2% |
2021 | HK$39.37 | 24.32% |
2020 | HK$31.67 | 45.88% |
2019 | HK$21.71 | 36.1% |
2018 | HK$15.95 | 105% |
2017 | HK$7.78 | 184.37% |
2016 | HK$2.74 | -260.69% |
2015 | -HK$1.70 |